Clinical Trial Update: Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hematopoietic stem cell transplantation after a chemotherapy-only cytoreduction with busulfan, cyclophosphamide, and fludarabine in Fan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Fanconi Anemia
• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Aplastic Anemia, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-07-10